Latest Updates
-
Chana Masala Recipe: Experience Dhaba Style Authentic Taste -
Struggling With Oily Skin This Summer? Simple Tips to Keep Shine Under Control -
Garlic Bread Recipe: The Cheesy Bakery Style Trick You Need -
Soha Ali Khan Swears By This ‘Gentle Game-Changer’ Lemon Drink for Gut Health: Full Recipe Inside -
World Health Day 2026: You’re Not As Healthy As You Think—Here’s Why -
One Pot Easy Lunch Recipe: Flavorful Veg Pulao -
Karan Aujla India Tour Controversy: Lucknow and Ludhiana Shows Cancelled—What Went Wrong? -
Kissing Disease Linked to 3x Higher Risk of Multiple Sclerosis: What You Should Know -
Feeling Drained in the Heat? 10 Healthy Drinks to Sip This Summer -
Happy Birthday Rashmika Mandanna: Steal Her White Looks For Easter 2026 Festive Parties And Celebrations
Mutant Protein
{image- www.boldsky.com} Researchers from Emory University have announced the development of an 'intrabody' tool that may help in wiping off the clusters of the mutant protein responsible for neurodegeneration in Huntington's disease.
They engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms damage brain cells of people with Huntington's.
When they injected the virus into the mice's brains that make mutant huntingtin improved their ability to move their limbs, although it does not prolong their lives.
Xiao-Jiang Li, PhD, senior author and professor of human genetics at Emory University School of Medicine said that though other researchers have shown that various intrabodies can protect cells from mutant huntingtin, their team was the first to examine the effects of an intrabody in living mice.
"Our goal here was to create a tool that could distinguish between the accumulation of mutant proteins in the nucleus and the cytoplasm," he said.
"The intrabody binds huntingtin proteins with expanded poly-glutamine regions and it only works in the cytoplasm, not the nucleus."
Mutant proteins have a region consisting of the same amino acid (glutamine) many times, called poly-glutamine, which makes the proteins clump together inside brain cells.
The study showed that cultured cells that make both the intrabody and mutant huntingtin are able to get rid of the mutant protein faster and have fewer clumps of huntingtin.
"Several neurodegenerative diseases appear to involve defects in protein folding and metabolism, leading to the accumulation of protein aggregates inside cells," he said.
"Our study suggests a strategy for dissecting the harmful effects of these protein aggregates in other diseases," he added.
The study appears online and is scheduled for publication in the May/June issue of the Journal of Cell Biology.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











